相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
HeRA: an atlas of enhancer RNAs across human tissues
Zhao Zhang et al.
NUCLEIC ACIDS RESEARCH (2021)
Functional roles of antisense enhancer RNA for promoting prostate cancer progression
Chun-Wu Pan et al.
THERANOSTICS (2021)
Tissue-resident memory T cells in breast cancer control and immunotherapy responses
Ann Byrne et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Enhancer RNAs in cancer: regulation, mechanisms and therapeutic potential
Joo-Hyung Lee et al.
RNA BIOLOGY (2020)
lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer
Yaqiong Zhang et al.
BREAST CANCER (2020)
Overcoming Endocrine Resistance in Breast Cancer
Ariella B. Hanker et al.
CANCER CELL (2020)
Inhibiting WNT Ligand Production for Improved Immune Recognition in the Ovarian Tumor Microenvironment
Whitney N. Goldsberry et al.
CANCERS (2020)
Elucidating Epigenetic Regulation by Identifying Functionalcis-Acting Long Noncoding RNAs and Their Targets in Osteoarthritic Articular Cartilage
Marcella van Hoolwerff et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Invasive apocrine carcinoma of the breast: clinicopathologic features and comprehensive genomic profiling of 18 pure triple-negative apocrine carcinomas
Xiangjie Sun et al.
MODERN PATHOLOGY (2020)
A High-Resolution Map of Human Enhancer RNA Loci Characterizes Super-enhancer Activities in Cancer
Han Chen et al.
CANCER CELL (2020)
Personalized early detection and prevention of breast cancer: ENVISION consensus statement
Nora Pashayan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer
Yucai Wu et al.
Aging-US (2020)
Progress in adjuvant systemic therapy for breast cancer
Noam F. Ponde et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
FABP7 is a key metabolic regulator in HER2+breast cancer brain metastasis
Alex Cordero et al.
ONCOGENE (2019)
Down-regulation of RAC2 by small interfering RNA restrains the progression of osteosarcoma by suppressing the Wnt signaling pathway
Peng Xia et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Bioinformatic profiling of prognosis-related genes in the breast cancer immune microenvironment
Fang Bai et al.
AGING-US (2019)
B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer
Daniel P. Hollern et al.
CELL (2019)
Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer
Zhao Zhang et al.
NATURE COMMUNICATIONS (2019)
Cytokines in clinical cancer immunotherapy
Pedro Berraondo et al.
BRITISH JOURNAL OF CANCER (2019)
WAKMAR2, a Long Noncoding RNA Downregulated in Human Chronic Wounds, Modulates Keratinocyte Motility and Production of Inflammatory Chemokines
Eva K. Herter et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status
Romain Cohen et al.
JAMA ONCOLOGY (2019)
Six novel immunoglobulin genes as biomarkers for better prognosis in triple-negative breast cancer by gene co-expression network analysis
Huan-Ming Hsu et al.
SCIENTIFIC REPORTS (2019)
A Muscle-Specific Enhancer RNA Mediates Cohesin Recruitment and Regulates Transcription In trans
Pei-Fang Tsai et al.
MOLECULAR CELL (2018)
HPSE enhancer RNA promotes cancer progression through driving chromatin looping and regulating hnRNPU/p300/EGR1/HPSE axis
Wanju Jiao et al.
ONCOGENE (2018)
Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics
Eisuke Miyauchi et al.
PLOS ONE (2018)
Classification of triple-negative breast cancers based on Immunogenomic profiling
Yin He et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Inflammatory breast cancer biology: the tumour microenvironment is key
Bora Lim et al.
NATURE REVIEWS CANCER (2018)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications
Saifullah Afridi et al.
IMMUNOLOGICAL REVIEWS (2016)
Enhancers as non-coding RNA transcription units: recent insights and future perspectives
Wenbo Li et al.
NATURE REVIEWS GENETICS (2016)
Enhancers: five essential questions
Len A. Pennacchio et al.
NATURE REVIEWS GENETICS (2013)
Cancer immunology-analysis of host and tumor factors for personalized medicine
Shuji Ogino et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Widespread transcription at neuronal activity-regulated enhancers
Tae-Kyung Kim et al.
NATURE (2010)
The KEGG databases at GenomeNet
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2002)
分享论文
